Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
Japan · Delayed Price · Currency is JPY 4,014.00
+3.00 (0.07%)
Oct 24, 2025, 3:30 PM JST
TYO:4530 Revenue
Hisamitsu Pharmaceutical Co. had revenue of 40.28B JPY in the quarter ending August 31, 2025, with 1.59% growth. This brings the company's revenue in the last twelve months to 155.49B, up 3.53% year-over-year. In the fiscal year ending February 28, 2025, Hisamitsu Pharmaceutical Co. had annual revenue of 156.01B with 10.09% growth.
Revenue (ttm)
155.49B
Revenue Growth
+3.53%
P/S Ratio
1.83
Revenue / Employee
55.55M
Employees
2,799
Market Cap
283.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 156.01B | 14.30B | 10.09% |
| Feb 29, 2024 | 141.71B | 13.38B | 10.42% |
| Feb 28, 2023 | 128.33B | 8.14B | 6.77% |
| Feb 28, 2022 | 120.19B | 5.68B | 4.96% |
| Feb 28, 2021 | 114.51B | -26.48B | -18.78% |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.48T |
| Otsuka Holdings | 2.40T |
| Astellas Pharma | 1.94T |
| Daiichi Sankyo Company | 1.92T |
| Chugai Pharmaceutical | 1.20T |
| Terumo | 1.04T |
| Olympus | 969.02B |
| HOYA Corporation | 876.09B |